C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L

被引:62
作者
Fournel, S
Wieckowski, S
Sun, WM
Trouche, N
Dumortier, H
Bianco, A
Chaloin, O
Habib, M
Peter, JC
Schneider, P
Vray, B
Toes, RE
Offringa, R
Melief, CJM
Hoebeke, J
Guichard, G
机构
[1] CNRS, UPR 9021, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France
[2] Free Univ Brussels, Fac Med, Expt Immunol Lab, B-1070 Brussels, Belgium
[3] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland
[4] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1038/nchembio746
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction between CD40, a member of the tumor necrosis factor receptor ( TNFR) superfamily, and its ligand CD40L, a 39-kDa glycoprotein, is essential for the development of humoral and cellular immune responses(1,2). Selective blockade or activation of this pathway provides the ground for the development of new treatments against immunologically based diseases(3,4) and malignancies(5,6). Like other members of the TNF superfamily, CD40L monomers self-assemble around a threefold symmetry axis to form noncovalent homotrimers that can each bind three receptor molecules(7,8). Here, we report on the structure-based design of small synthetic molecules with C-3 symmetry that can mimic CD40L homotrimers. These molecules interact with CD40, compete with the binding of CD40L to CD40, and reproduce, to a certain extent, the functional properties of the much larger homotrimeric soluble CD40L. Architectures based on rigid C-3- symmetric cores may thus represent a general approach to mimicking homotrimers of the TNF superfamily.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 31 条
[1]   ANALYSIS OF GP39/CD40 INTERACTIONS USING MOLECULAR-MODELS AND SITE-DIRECTED MUTAGENESIS [J].
BAJORATH, J ;
MARKEN, JS ;
CHALUPNY, NJ ;
SPOON, TL ;
SIADAK, AW ;
GORDON, M ;
NOELLE, RJ ;
HOLLENBAUGH, D ;
ARUFFO, A .
BIOCHEMISTRY, 1995, 34 (31) :9884-9892
[2]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[3]   The molecular architecture of the TNF superfamily [J].
Bodmer, JL ;
Schneider, P ;
Tschopp, J .
TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (01) :19-26
[4]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[5]  
Chaussabel D, 1999, INFECT IMMUN, V67, P1929
[6]   Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine [J].
Cwirla, SE ;
Balasubramanian, P ;
Duffin, DJ ;
Wagstrom, CR ;
Gates, CM ;
Singer, SC ;
Davis, AM ;
Tansik, RL ;
Mattheakis, LC ;
Boytos, CM ;
Schatz, PJ ;
Baccanari, DP ;
Wrighton, NC ;
Barrett, RW ;
Dower, WJ .
SCIENCE, 1997, 276 (5319) :1696-1699
[7]   CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy [J].
Diehl, L ;
den Boer, AT ;
Schoenberger, SP ;
van der Voort, EIH ;
Schumacher, TNM ;
Melief, CJM ;
Offringa, R ;
Toes, REM .
NATURE MEDICINE, 1999, 5 (07) :774-779
[8]   The role of CD40 in peripheral T cell tolerance and immunity [J].
Diehl, L ;
Den Boer, AT ;
van der Voort, EIH ;
Melief, CJM ;
Offringa, R ;
Toes, REM .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (07) :363-371
[9]   Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection [J].
Edelmann, KH ;
Wilson, CB .
JOURNAL OF VIROLOGY, 2001, 75 (02) :612-621
[10]  
Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO